October 19, 2022
On Jan. 1, 2023, cost sharing for insulin products will be capped at $35, which may be less than plans’ stated cost share.
Also, effective Jan. 1, 2023, adult vaccines recommended by the Centers for Medicare & Medicaid Services will be covered at $0 cost share.
Why it matters:
The insulin cost share cap and $0 cost share adult vaccines will be provided regardless of formulary tier or benefit phase.
To read the full News from the Blues newsletter, log in to Blue Access for ProducersSM (BAPSM).